no image available Dickens & Co. "Beating the Odds: Amrubicin's Unexpected Impact on Lung Cancer Metastases" "A Case Series of Eight Patients Sheds New Light on the Drug's Potential in Treating Central Nervous System Tumors" Price: 24.00€